The most widely prescribed medications for osteoporosis are bisphosphonates such as alendronate, risedronate, and ibandronate, which can cause side effects like nausea, abdominal pain, and esophageal issues if not taken properly. Estrogen therapy after menopause can help maintain bone density but increases health risks, while raloxifene mimics estrogen's bone benefits with fewer risks and may reduce breast cancer risk. Other options include teriparatide injections that stimulate new bone growth for two years, and denosumab shots every six months that produce bone density results similar to or better than bisphosphonates while targeting a different process with potential back and muscle pain as common side effects
My Mifespristone and Misoprostol Story: How I used mifepristone and misoprostol for a successful medical abortion and all you must know about these abortion pills
The most widely prescribed medications for osteoporosis are bisphosphonates such as alendronate, risedronate, and ibandronate, which can cause side effects like nausea, abdominal pain, and esophageal issues if not taken properly. Estrogen therapy after menopause can help maintain bone density but increases health risks, while raloxifene mimics estrogen's bone benefits with fewer risks and may reduce breast cancer risk. Other options include teriparatide injections that stimulate new bone growth for two years, and denosumab shots every six months that produce bone density results similar to or better than bisphosphonates while targeting a different process with potential back and muscle pain as common side effects
The most widely prescribed medications for osteoporosis are bisphosphonates such as alendronate, risedronate, and ibandronate, which can cause side effects like nausea, abdominal pain, and esophageal issues if not taken properly. Estrogen therapy after menopause can help maintain bone density but increases health risks, while raloxifene mimics estrogen's bone benefits with fewer risks and may reduce breast cancer risk. Other options include teriparatide injections that stimulate new bone growth for two years, and denosumab shots every six months that produce bone density results similar to or better than bisphosphonates while targeting a different process with potential back and muscle pain as common side effects
The most widely prescribed medications for osteoporosis are bisphosphonates such as alendronate, risedronate, and ibandronate, which can cause side effects like nausea, abdominal pain, and esophageal issues if not taken properly. Estrogen therapy after menopause can help maintain bone density but increases health risks, while raloxifene mimics estrogen's bone benefits with fewer risks and may reduce breast cancer risk. Other options include teriparatide injections that stimulate new bone growth for two years, and denosumab shots every six months that produce bone density results similar to or better than bisphosphonates while targeting a different process with potential back and muscle pain as common side effects
The most widely prescribed osteoporosis medications are
bisphosphonates. Examples include:
Alendronate (Fosamax, Binosto)
Risedronate (Actonel, Atelvia)
Ibandronate (Boniva)
Zoledronic acid (Reclast, Zometa)
Side effects include nausea, abdominal pain, difficulty swallowing, and
the risk of an inflamed esophagus or esophageal ulcers. These are less likely to occur if the medicine is taken properly. Hormone-related therapy Estrogen, especially when started soon after menopause, can help maintain bone density. However, estrogen therapy can increase a woman's risk of blood clots, endometrial cancer, breast cancer and possibly heart disease. Raloxifene (Evista) mimics estrogen's beneficial effects on bone density in postmenopausal women, without some of the risks associated with estrogen. Taking this drug may also reduce the risk of some types of breast cancer.
Teriparatide (Forteo). This powerful drug is similar to parathyroid
hormone and stimulates new bone growth. It's given by injection under the skin. After two years of treatment with teriparatide, another osteoporosis drug is taken to maintain the new bone growth.
Denosumab (Prolia). Compared with bisphosphonates, denosumab
produces similar or better bone density results while targeting a different step in the bone remodeling process. Denosumab is
Thursday, November 6, 2014
delivered via a shot under the skin every six months. The most common side effects are back and muscle pain.
My Mifespristone and Misoprostol Story: How I used mifepristone and misoprostol for a successful medical abortion and all you must know about these abortion pills